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Conclusion: We measured neutron spectra and calculated 
neutron dose equivalents for a clinical treatment for a single 
gantry proton system, whose use and planned installations 
have recently increased. Data reported here are consistent 
with dose equivalents reported for CSI carried out with other 
proton therapy beamlines. 
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Purpose or Objective: More than half of cancer patients 
receive radiotherapy for radical or palliative purposes. 
Increasing survival rates in cancer patients make it important 
to study late side-effects, including secondary radiation-
induced cancers. Although a number of predictive models 
exist, the absolute accuracy of these models in the 
radiotherapy dose range is limited partly due to scarcity of 
data and partly by extrapolation beyond historical data 
bounds. The aim of this work is to investigate conversion of 
malignant induction probabilities, which provide useful 
relative risk estimates, into absolute life time attributable 
risk estimates (LAR) and excess absolute risk (EAR) by 
calibrating and benchmarking our models using published 
outcome data. 
 
Material and Methods: An in-house modelling tool, which 
calculates voxelwise risk estimates from patient-specific 3D 
dose distributions, was modified to generate linear-no-
threshold (LNT) model-based risk estimates for the whole 
body and per organ using organ-equivalent dose. Second 
cancer risk was calculated for uniform whole-body exposure 
of 0.1 Gy for comparison with tabulated BIER VII data. Model 
parameters initially used were taken from existing published 
reports for the relevant models. The calculated LAR was then 
compared to the BIER VII results and the linear coefficient, λ, 
was adjusted to make the model prediction better match the 
BEIR VII result. A similar calibration of parameters was then 
performed for the linear quadratic (LQ) and linear model 
(LIN) malignant induction coefficients. EAR was calculated 
for a dose range to compare results with published data.  
 
Results: After calibration, calculations of LAR for single 
uniform exposure of 0.1 Gy produced a value of 837 cases per 
100,000 for an exposure at age of 40, in comparison to 824 
according to BIER VII report. Averaging over ages at exposure 
of 20 to 80 produced a value within 5% of the BIER VII report. 
Calculations of EAR for a dose range relevant to RT of 1-6 Gy 
using the LIN model were always within the range of 
uncertainty due to differences in RBE neutron value in the 
independent published Hodgkin Lymphoma data (Schneider et 
al, 2008).  
 
 
 
Conclusion: These results show that our models can produce 
absolute LAR estimates for secondary cancer which are 
consistent with the values reported in the BEIR VII report for 
uniform irradiation to 0.1Gy. The comparison of our results of 
EAR using LIN model to published data showed agreement 
with independent published data of HL.  
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Purpose or Objective: There is increased use of proton 
therapy in pediatric cancer patients. In treatment planning, 
neutrons produced in the treatment delivery system and the 
patient are usually ignored and not documented. The goal of 
this ongoing project is to develop and establish a system for 
measuring and simulating 3D neutron and gamma radiation 
fields of passively scattered and actively scanned proton 
beams using representative clinical proton fields impinging on 
tissue-equivalent phantom materials. Eventually this should 
lead to a standardized approach for calculating organ neutron 
doses in paediatric proton patients. 
 
Material and Methods: The neutron dosimetry consists of 
neutron and gamma fluence measurements with an array of 
three organic scintillators positioned 70-80 cm lateral to 
blocks of tissue equivalent materials (soft tissue and compact 
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bone, CIRS) which are at isocenter and irradiated with 
therapeutic protons beams. The tissue equivalence of the 
irradiated materials for neutron doses (per incident proton) 
and energy spectra has previously been established with 
Geant4 simulations. Pulse shape discrimination is used to 
classify each detected pulse as either a neutron or a gamma 
ray, which allows selective analysis of the neutron and 
gamma ray spectra. Data are acquired using a digital 
measurement system based on a CAEN DT5720 waveform 
digitizer (12 bit, 250 MHz). The response of the scintillators is 
also simulated using a detection post-processor distributed 
with a modified version of MCNPX (PoliMi code). To validate 
the code, the total simulated neutron pulse height 
distributions scaled to the absolute fluence recorded during 
the measurements is compared with the measured 
distributions from the scintillators. 
 
Results: There was good agreement (within 10%) of neutron 
dose and energy spectra for investigated tissue equivalent 
materials when compared to ICRP human tissues. So far 
measurements have been performed at three different 
proton treatment centers and measurements at two 
additional centers are planned, thus testing the system on a 
range of contemporary proton beam accelerators and beam 
delivery systems. Good agreement was found between the 
detector responses and Monte Carlo simulations. Using 
MCPNX, it was shown that the secondary neutron field can be 
separated into two distinct components; an isotropic, low-
energy component and a forward-directed, high-energy 
component. 
 
Conclusion: The neutron dosimetry system is applicable to 
any proton facility and will be valuable for prospective data 
collection of neutron doses and second cancer risk 
evaluation, thus establishing the dosimetric basis for a 
prospective clinical data base for paediatric proton patients. 
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Purpose or Objective: The study presented here is three-
part work whose primary aims were to determine a) the 
properties of the scattered radiation responsible for out-of-
field doses b) the out-of-field radiation doses at varying 
distances from the primary beam, and c) the impact of these 
doses to biological response of in-vitro cells. 
 
Material and Methods: We developed a purpose-designed 
water phantom to study out-of-field radiation. The phantom 
consists of seven dual-purpose inserts that can be used to 
measure doses and to assess radiobiological effects at the 
same measuring points. The photon (6 MV) energy spectra 
were calculated at 5 unique positions (at depths of 0.5 1.6, 
4, 6, 8, and 10 cm) along the central beam axis (CAX) and at 
six different off-axis distances. To gain a better 
understanding of out-of-field doses, we measure the 
individual contribution of photons and neutrons to the total 
out-of-field dose for 6 MV and 20MV photons at open beam. 
Radiation doses were measured at 6 separate points in the 
phantom with TLD 100, TLD 600, TLD 700, and Gafchromic 
EBT films. Cells from the human breast cancer line MDA-MB-
231 were inserted in a water phantom and irradiated at CAX 
and off-axis distance, at varying doses (1.5, 2.0, 2.5, 3.0 Gy). 
Survival fraction, number of DNA double strand-breaks (DNA 
DSBs), and cleaved PARP levels were determined by 
clonogenic assay and flow cytometry. 
 
Results: Measured Monte Carlo simulations showed that mean 
radiation energy levels drop rapidly beyond the edge of the 6 
MV photon beam field (Table 1). Simulations showed that the 
energy level actually increased slightly in some cases as the 
distance from the field edge increased. At a prescribed dose 
of 75 Gy to the isocentre, the measured photon dose level in 
the close-to-field area could reach up to 2.0-2.5Gy for 6MV 
and 1.5-2.0Gy for 20MV. Although the dose decreased rapidly 
as the distance from the CAX increased, even distant doses 
could reach several cGy when photons were used (Fig. 1). 
The neutron dose for 20 MV photons at a distance of 25 cm 
from the isocentre was 3.5 mSv/Gy. A slight non-significant 
decrease of 3-5% in cell SF was observed in cells irradiated 
outside the primary field. 
 
 
 
 
Conclusion: The dose levels measured in this study strongly 
suggest that out-of-field doses (especially for 20 MV) should 
be taken in consideration to obtain radiation protection of 
patients, as these dose levels could increase second cancer 
risk. Scattered irradiation appears to induce an in vitro 
biological response on out-of-field cells. 
 
Poster: Physics track: Treatment plan optimisation: 
algorithms  
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Purpose or Objective: Treatment plans for head and neck 
(H&N) cancer are highly complex due to multiple dose 
prescription levels and numerous organs at risk (OAR) close to 
the target. The plan quality is inter-planner dependent since 
it is dependent on the skills and experience of the 
dosimetrist. This study presents a blinded clinical comparison 
